(12) United States Patent (10) Patent No.: US 9,108,907 B1 HL (45) Date of Patent: Aug

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 9,108,907 B1 HL (45) Date of Patent: Aug US009108907B1 (12) United States Patent (10) Patent No.: US 9,108,907 B1 HL (45) Date of Patent: Aug. 18, 2015 (54) PROCESS FOR THE PRODUCTION OF (56) References Cited TAURINE FROMETHANOL U.S. PATENT DOCUMENTS (71) Applicant: Songzhou Hu, Princeton, NJ (US) 3,637.793 A * 1/1972 Lamberti ...................... 562/101 4,435,328 A * 3/1984 Lamberti et al. ................ 554.92 (72) Inventor: Songzhou Hu, Princeton, NJ (US) OTHER PUBLICATIONS Notice: Subject to any disclaimer, the term of this Manual of Patent Examining Procedure (MPEP) Ninth Edition, Mar. (*) 2014 section 714 "Amendments to the Claims’. patent is extended or adjusted under 35 Machine Translation of CN10148669 taken from espacnet.com.* U.S.C. 154(b) by 0 days. Breslow etal, Synthesis of Sodium Ethylenesulfonate from Ethanol J. Am..Chem.Soc., 1954, vol. 76, pp. 5361-5363. (21) Appl. No.: 13/999,203 * cited by examiner (22) Filed: Jan. 29, 2014 Primary Examiner — Karl J. Puttlitz (51) Int. C. (57) ABSTRACT C07C303/22 (2006.01) The present invention discloses a process for the preparation (52) U.S. C. of taurine from ethionic acid and ethanol by way of ethanol CPC .................................... C07C303/22 (2013.01) derived ethionic acid by the ammonolysis of ethionic acid and (58) Field of Classification Search by the ammonolysis of Sodium isethionate and Sodium vinyl None Sulfonate, key intermediates prepared from ethionic acid. See application file for complete search history. 2 Claims, 3 Drawing Sheets Production of Taurine via Ethionic Acid Ethanol Ethionic Acid Ammonia Evaporation Bleeding Fitration Solution Water Taurine & Ammonium Sulfate Filtration Annoniurn Sulfate Crystallization Filtration Filtration TAURINE Ammonium Sulfate U.S. Patent Aug. 18, 2015 Sheet 1 of 3 US 9,108,907 B1 Fig. 1. Production of Taurine via Ethionic Acid Ethanol 2SO3 Ammonia t Water Filtration Ammonium Sulfate Recrystallization Crystallization Filtration Filtration TAURINE Ammonium Sulfate U.S. Patent Aug. 18, 2015 Sheet 2 of 3 US 9,108,907 B1 Fig. 2. Production of Taurine via Sodium lsethionate Ethanol Ethionic Acid 2SO3 Water Sethionic Acid & Sulfuric Acid CaO or Sodium Sethionate di Sulfat Ca(OH)2 Calcium Sulfate Sodium Sulfate Filtration wavvannawawawa unawaw Calcium Sulfate Sodium sethionate Ammonia Sulfuric Acid Sodium Sulfate TAURINE U.S. Patent Aug. 18, 2015 Sheet 3 of 3 US 9,108,907 B1 Fig. 3. Production of Taurine via Sodium Vinyl Sulfonate Ethanol Ethionic Acid 2SO3 CaO or Sodium Vinyl Sulfonate f Ca(OH)2 Calcium Sulfate Sodium Sulfate Filtration WWMX101WWM Calcium Sulfate Sodium Vinyl Sulfonate Ammonia Sulfuric Acid Sodium Sulfate TAURINE US 9,108,907 B1 1. 2 PROCESS FOR THE PRODUCTION OF FIG.3 is a flow chart showing the third embodiment of the TAURINE FROMETHANOL present invention as a block diagram wherein taurine is pro duced by ammonolyis of sodium vinylsulfate intermediate TECHNICAL FIELD prepared from ethanol-derived ethionic acid. This invention relates generally to taurine and more par DESCRIPTION OF THE INVENTION ticularly to a process for the production of taurine from ethionic acid and ethanol by way of ethanol-derived ethionic In accordance with the present invention, there are dis acid. closed three preferred embodiments for producing taurine 10 from ethionic acid and more specifically from ethanol by way BACKGROUND OF THE INVENTION of ethanol-derived ethionic acid. These three embodiments are schematically illustrated in FIGS. 1 to 3 as a block dia Taurine can be referred to as 2-aminoethanesulfonic acid gram. and is one of the amino Sulfonic acids found in the tissues of In the first preferred embodiment of the present invention, many animals. Taurine is an extremely useful compound 15 because it has such pharmacological effects as detoxification ethionic acid is reacted with an aqueous solution of excess effect, fatigue-relieving effect and nourishing and tonifying ammonia to afford ammonium ethionate. The molar ratio of effect. As a result, taurine finds wide applications as an essen ammonia to ethionic acid can be in the range of 5 to 15, more tial ingredient for human and animal nutrition. preferably in the range of 8 to 10. Too little ammonia Taurine is currently produced in an amount of over 50,000 increases the formation of ditaurine, a byproduct, while more tons per year from ethylene oxide and monoethanolamine, ammonia is desirable for the reaction, too much ammonia both of which are petroleum derived chemicals. In addition to increases the process cost in the recovery of excess ammonia. their ever increasing cost, these two starting materials are The reactions are described as follows: toxic and for ethylene oxide difficult to handle. An alternate process for producing taurine from non-petroleum chemical 25 is, therefore, desirable. Such a process would be even more 1No + 2SOs —- Hos1 O N1)son valuable if taurine could be produced at a lower and more Ethionic Acid stable cost. O Ethanol is easily available at reasonable cost from natural HOs1 N-1Nson -- 3NH He Sources by fermentation as it is produced in large quantity as 30 HN a fuel additive and as an industrially important chemical. Y1NSOH (NH);so, Furthermore, an industrially applicable process for the con Taurine version of ethanol into ethionic acid is already known (U.S. Pat. No. 3,637.793, incorporated herein, by reference). This When the aqueous ammonia Solution of ammonium invention discloses novel methods for the conversion of etha 35 ethionate is Subjected to the ammonolysis reaction at a tem nol-derived ethionic acid into taurine. perature of 100 to 250° C., preferably from 130 to 220° C., at The disclosed process can also be applied to the production a pressure from the autogenous to 250 bar, preferably from of taurine from ethionic acid prepared from other materials 100 to 150 bar, ammonium ethionate is converted to taurine Such as ethylene and carbyl Sulfate. and ammonium sulfate, along with the formation of some It is, therefore, an object of this invention to provide a 40 ammonium isethionate. The ammonolysis can also be carried process for producing taurine from ethanol via ethanol-de out in the presence of catalyst Such as the alkaline salts of rived ethionic acid, which is economical and more competi Sodium, potassium and lithium. Such salts are sodium tive than current industrial processes using ethylene oxide hydroxide, potassium hydroxide, lithium hydroxide, Sodium and monoethanolamine as starting materials. carbonate, potassium carbonate, lithium carbonate, sodium It is another object of the present invention to disclose a 45 Sulfate, Sodium sulfite, potassium sulfate, potassium sulfite. process for the conversion of ethionic acid into sodium Any one or a combination of two or more these salts can be isethionate and Sodium vinyl Sulfonate, key intermediates for used as catalyst to influence the reaction. producing taurine from ethionic acid by a combined use of It is Surprising to disclose in the present invention that no calcium oxide/calcium hydroxide and Sodium Sulfate as alka acid neutralization of the aqueous Solution is needed when line media. 50 excess ammonia is removed first by flash distillation, then by It is a further object of the present invention to disclose a evaporation under vacuum. The concentrated Solution shows process for the cyclic use of alkali metal ions, more specifi a pH of 5-6, and upon cooling, taurine is crystallized and can cally, Sodium ion in the form of sodium sulfate, sodium be separated by filtration. Further concentration of the mother isethionate, and sodium ethionate, in the production of tau liquor results in the crystallization of a mixture of taurine and rine from ethionic acid via key intermediates of sodium 55 ammonium sulfate. The separation of taurine and ammonium isethionate and sodium vinyl Sulfonate. Sulfate can be accomplished according to a process disclosed in the Co-pending application, titled Cyclic Process for the DESCRIPTION OF THE DRAWINGS Production of Taurine from Monoethanolamine, incorpo rated herein in FIG.1. Crude taurine is upgraded to a product FIG. 1 is a flow chart showing the first embodiment of the 60 of pharmaceutical grade after one or more recrystallization in present invention as a block diagram wherein taurine is pro deionized water. duced by direct ammonolysis of ethanol-derived ethionic In the second preferred embodiment, ethionic acid, more acid. specifically, ethanol-derived ethionic acid, is first converted FIG. 2 is a flow chart showing the second embodiment of to sodium isethionate, which is then subjected to the the present invention as a block diagram wherein taurine is 65 ammonolysis reaction to yield Sodium taurinate. The process produced by ammonolyis of sodium isethionate intermediate is schematically illustrated in FIG. 2 and the reaction schemes prepared from ethanol-derived ethionic acid. are as follows: US 9,108,907 B1 4 invention is operationally simpler, and more economical. The O process requires only the monitoring of the pH in the reaction Hos1 Y1, YSOH Ho - system. Moreover, the costly base of sodium hydroxide is HON1 Nson + H2SO ->Ca(OH)2 + Na2SO4 replaced with the inexpensive calcium oxide or calcium 5 hydroxide, and sodium is introduced into the product in the "N1)-son, + CaSO4 form of sodium sulfate, which by itself is a byproduct in the production of taurine. "N1)-son, + NH3 -> "n-1\son, It is apparent from FIG. 2 that sodium sulfate is recycled "N-1\son, + H2SO4 -> continuously in the production of taurine from ethionic acid 10 by way of intermediate sodium isethionate, thus eliminating "N-1so + Na2SO4 an otherwise waste discharge. An added advantage is the increased recovery yield of taurine, since sodium Sulfate Production of alkali isethionate from ethionic acid is separated from its mixture with taurine invariably contains a 15 Small amount of taurine. This cyclic use of sodium sulfate in already known (U.S. Pat.
Recommended publications
  • Thesis, Dissertation
    THE COENZYME M BIOSYNTHETIC PATHWAY IN PROTEOBACTERIUM XANTHOBACTER AUTOTROPHICUS PY2 by Sarah Eve Partovi A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biochemistry MONTANA STATE UNIVERSITY Bozeman, Montana January 2018 ©COPYRIGHT by Sarah Eve Partovi 2018 All Rights Reserved ii DEDICATION I dedicate this dissertation to my family, without whom none of this would have been possible. My husband Ky has been a part of the graduate school experience since day one, and I am forever grateful for his support. My wonderful family; Iraj, Homa, Cameron, Shireen, Kevin, Lin, Felix, Toby, Molly, Noise, Dooda, and Baby have all been constant sources of encouragement. iii ACKNOWLEDGEMENTS First, I would like to acknowledge Dr. John Peters for his mentorship, scientific insight, and for helping me gain confidence as a scientist even during the most challenging aspects of this work. I also thank Dr. Jennifer DuBois for her insightful discussions and excellent scientific advice, and my other committee members Dr. Brian Bothner and Dr. Matthew Fields for their intellectual contributions throughout the course of the project. Drs. George Gauss and Florence Mus have contributed greatly to my laboratory technique and growth as a scientist, and have always been wonderful resources during my time in the lab. Members of the Peters Lab past and present have all played an important role during my time, including Dr. Oleg Zadvornyy, Dr. Jacob Artz, and future Drs. Gregory Prussia, Natasha Pence, and Alex Alleman. Undergraduate researchers/REU students including Hunter Martinez, Andrew Gutknecht and Leah Connor have worked under my guidance, and I thank them for their dedication to performing laboratory assistance.
    [Show full text]
  • NON-HAZARDOUS CHEMICALS May Be Disposed of Via Sanitary Sewer Or Solid Waste
    NON-HAZARDOUS CHEMICALS May Be Disposed Of Via Sanitary Sewer or Solid Waste (+)-A-TOCOPHEROL ACID SUCCINATE (+,-)-VERAPAMIL, HYDROCHLORIDE 1-AMINOANTHRAQUINONE 1-AMINO-1-CYCLOHEXANECARBOXYLIC ACID 1-BROMOOCTADECANE 1-CARBOXYNAPHTHALENE 1-DECENE 1-HYDROXYANTHRAQUINONE 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE HYDROCHLORIDE 1-NONENE 1-TETRADECENE 1-THIO-B-D-GLUCOSE 1-TRIDECENE 1-UNDECENE 2-ACETAMIDO-1-AZIDO-1,2-DIDEOXY-B-D-GLYCOPYRANOSE 2-ACETAMIDOACRYLIC ACID 2-AMINO-4-CHLOROBENZOTHIAZOLE 2-AMINO-2-(HYDROXY METHYL)-1,3-PROPONEDIOL 2-AMINOBENZOTHIAZOLE 2-AMINOIMIDAZOLE 2-AMINO-5-METHYLBENZENESULFONIC ACID 2-AMINOPURINE 2-ANILINOETHANOL 2-BUTENE-1,4-DIOL 2-CHLOROBENZYLALCOHOL 2-DEOXYCYTIDINE 5-MONOPHOSPHATE 2-DEOXY-D-GLUCOSE 2-DEOXY-D-RIBOSE 2'-DEOXYURIDINE 2'-DEOXYURIDINE 5'-MONOPHOSPHATE 2-HYDROETHYL ACETATE 2-HYDROXY-4-(METHYLTHIO)BUTYRIC ACID 2-METHYLFLUORENE 2-METHYL-2-THIOPSEUDOUREA SULFATE 2-MORPHOLINOETHANESULFONIC ACID 2-NAPHTHOIC ACID 2-OXYGLUTARIC ACID 2-PHENYLPROPIONIC ACID 2-PYRIDINEALDOXIME METHIODIDE 2-STEP CHEMISTRY STEP 1 PART D 2-STEP CHEMISTRY STEP 2 PART A 2-THIOLHISTIDINE 2-THIOPHENECARBOXYLIC ACID 2-THIOPHENECARBOXYLIC HYDRAZIDE 3-ACETYLINDOLE 3-AMINO-1,2,4-TRIAZINE 3-AMINO-L-TYROSINE DIHYDROCHLORIDE MONOHYDRATE 3-CARBETHOXY-2-PIPERIDONE 3-CHLOROCYCLOBUTANONE SOLUTION 3-CHLORO-2-NITROBENZOIC ACID 3-(DIETHYLAMINO)-7-[[P-(DIMETHYLAMINO)PHENYL]AZO]-5-PHENAZINIUM CHLORIDE 3-HYDROXYTROSINE 1 9/26/2005 NON-HAZARDOUS CHEMICALS May Be Disposed Of Via Sanitary Sewer or Solid Waste 3-HYDROXYTYRAMINE HYDROCHLORIDE 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE
    [Show full text]
  • United States Patent Office Patented Mar
    3,243,454 United States Patent Office Patented Mar. 29, 1966 2 time. A preferred method of carrying out our process 3,243,454 PROCESS OF PREPARING ALKAL METAL is to reflux an aqueous solution of an alkali metal is SETIONATES ethionate and then remove excess water by evaporation. Donald L. Klass, Barrington, and Thomas W. Martinek, The following non-limiting examples illustrate the scope Crystal Lake, ii., assignors, by mesne assignments, to of our invention and, to a limited extent, compare our Union Oil Corpany of California, Los Angeles, Calif., invention with the prior art. a corporation of California Example I No Drawing. Filed Apr. 4, 1962, Ser. No. 184,939 6 Claims. (C. 260-513) A 5.0-g. portion of sodium vinyl sulfonate was dis O Solved in 50 ml. of water and the solution was refluxed This invention relates to new and useful improvements for 6 hours, with air-blowing. Evaporation of the excess in methods for the preparation of alkali metal salts of Water gave sodium isethionate in quantitative yield. The isethionic acid. identification of the product was by elemental analysis: The preparation of the alkali metal salts of isethionic calculated C, 16.22% wt., H, 3.40% wt., S, 21.65% wt., acid from ethylene oxide and an alkali metal bisulfite using 15 Na, 15.53% wt. Found: C, 16.8% wt., H, 3.4% wt., S, high pressure equipment is known in the art (see Sexton 22.2% wt., Na, 15.3% wt. Infrared analysis indicated et al. U.S. Patent 2.810,747).
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,696,773 Lukenbach Et Al
    United States Patent (19) 11 Patent Number: 4,696,773 Lukenbach et al. 45 Date of Patent: Sep. 29, 1987 54) PROCESS FOR THE PREPARATION OF (56) References Cited SETHONCACID U.S. PATENT DOCUMENTS (75) Inventors: Elvin R. Lukenbach, Somerset; 4,499,028 2/1985 Longley .............................. 260/513 Prakash Naik-Satam, East Windsor, both of N.J.; Anthony M. Schwartz, FOREIGN PATENT DOCUMENTS Rockville, Md. 0151934 11/1981 Fed. Rep. of Germany ...... 260/513 (73) Assignee: Johnson & Johnson Baby Products Primary Examiner-Alan Siegel Company, New Brunswick, N.J. Attorney, Agent, or Firm-Steven P. Berman 21) Appl. No.: 882,660 57) ABSTRACT Fied: Jul. 7, 1986 A process for the preparation of isethionic acid involv 22 ing the reaction of sodium isethionate and hydrogen 51 Int. Cl. ............................................ C07C 143/02 chloride in an alcoholic solvent is described. (52) U.S.C. ................................................ 260/513 R 58) Field of Search ........................ 260/513 R, 513 B 3 Claims, No Drawings 4,696,773 1 2 These and other objects of the present invention will PROCESS FOR THE PREPARATION OF become apparent to one skilled in the art from the de SETHONCACD tailed description given hereinafter. FIELD OF INVENTION SUMMARY OF THE INVENTION This invention relates to a process for the preparation This invention relates to a novel process for the prep of isethionic acid involving the reaction of sodium ise aration of isethionic acid. thionate and hydrogen chloride in an alcoholic solvent. BACKGROUND OF THE INVENTION 10 DETALED DESCRIPTION OF THE This invention relates to a process for the preparation INVENTION ofisethionic acid.
    [Show full text]
  • Abstract Reports: Student-Originated Studies Projects, 1973. INSTITUTION National Science R0,4Dation, Washington, D.C
    DOCUMENT RESUME ED 100 708 SE 018 648 AUTHOR Hill, Berton F., Ed. TITLE Abstract Reports: Student-Originated Studies Projects, 1973. INSTITUTION National Science r0,4dation, Washington, D.C. REPORT NO NSF-74-33 PUB DATE Dec 73 NOTE .88p.; Presented at the Project Reporting Meeting (Washington, D.C., December 26-29, 1973) EDRS PRICE MF-$0.75 HC-$13.80 PLUS POSTAGE DESCRIPT(IRS *Abstracts; College Students; *Environmental Research; Health; *Research; Science Education; *Sciences; *Student Projects; Student Research; Water Pollution Control IDENTIFIERS National Science Foundation; NSF; Research. Reports ABSTRACT Presented is a collection of research reports of college-age investigators. The work of the students demonstrates one way in which reliable andilluminating data.on local problems of societal importance can be gathered and analyzed in relatively short time-spans for very little money. Water-related studies, health-related and basic environmental studies are prei,-nted in abstract form: Included in each paper are the college in which the student investigators were enrolled, the participants in each particular research endeavor, the student project director, and faculty advisor. (EB) I I U.S. DEPARTMENT OF HEALTH, EDUCATION & WELFARE NATIONAL INSTITUTE OF EDUCATION THIS DOCUMENT HAS BEEN REPRO DUCED EXACTLY AS RECEIVED FROM THE PERSON OR ORtiANIZATION ORIGIN ATING IT POINTS OF VIEW OR OPINIONS STUDENT-ORIGINATED STATED DO NOT NECESSARILY REPRE SENT OFFICIAL NATIONAL INSTITUTE OF STUDIES PROJECTS EDUCATION POSITION OR POLICY BEST COPY AVAILABLE 1973 Abstract Reports Presented at Meetings in Washington, D.C. December 26-29, 1973 NATIONAL SCIENCE FOUNDATION bo Washington, D.C. 20550 to NSF 74.33 STUDENT-ORIGINATED STUDIES PROJECTS 1973 Abstract Reports Presented at the Project Reporting Meeting December 26-29, 1973 Washington, D.C.
    [Show full text]
  • Cir Expert Panel Meeting June 10-11, 2013
    PINK Safety Assessment of Isethionate Salts as Used in Cosmetics CIR EXPERT PANEL MEETING JUNE 10-11, 2013 Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Christina L. Burnett Scientific Writer/Analyst Date: May, 2013 Subject: Draft Tentative Report on Isethionate Salts Way back in December 2008, the CIR Expert Panel re‐reviewed Sodium Cocoyl Isethionate and determined to re‐open the report to allow for the development and incorporation of new reproductive and developmental data from Industry. The data at the time were not ready and the Panel agreed to table the report until the data were ready. The data were supposed to be available by the end of 2009. Meanwhile, at the March 2009 meeting with the newest Panel members seated, the Panel agreed to expand the ingredient report to include additional isethionate salts to bring the total number of ingredients reviewed in this safety assessment to 12. Nearly 5 years have passed and we never received the promised data directly from Industry. We have been recently informed that the data were submitted for REACH and can be accessed through the European Chemicals Agency (ECHA) website (http://echa.europa.eu/en/information‐on‐chemicals). While we are waiting on legal clarification in general on how we can proceed with utilizing copyrighted material from the ECHA site for unknown third party data, we have been given permission to use the data on sodium isethionate (CAS # 1562‐00‐1) from all involved parties. These data have been incorporated into the report. In the time that has passed, the reported uses to the FDA VCRP database have doubled for sodium cocoyl isethionate.
    [Show full text]
  • United States Patent (10) Patent No.: US 6,537,532 B1 Torgerson Et Al
    USOO6537532B1 (12) United States Patent (10) Patent No.: US 6,537,532 B1 Torgerson et al. (45) Date of Patent: *Mar. 25, 2003 (54) SILICONE GRAFTED THERMOPLASTIC (52) U.S. Cl. ................ 424/70.12; 424/70.1; 424/70.11; ELASTOMERIC COPOLYMERS AND HAIR 424/70.15; 424/70.16; 424/78.08; 424/78.17; AND SKIN CARE COMPOSITIONS 424/78.24 CONTAINING THE SAME (58) Field of Search ............................. 424/70.12, 70.1, 424/70.11, 70.15, 70.16, 78.08, 78.17, 78.24 (75) Inventors: Peter Marte Torgerson, Washington Court House, OH (US); Sanjeev (56) References Cited Midha, Blue Ash, OH (US) U.S. PATENT DOCUMENTS (73) Assignee: The Procter & Gamble Company, 4.011,376 A 3/1977 Tomalia et al. ............. 528/392 Cincinnati, OH (US) 4,988,506 A * 1/1991 Mitra et al. ............ 424/70.122 5,106,609 A * 4/1992 Bolich, Jr. et al............. 424/70 (*) Notice: Subject to any disclaimer, the term of this 5,916,547 A * 6/1999 Torgerson et al. ....... 424/70.12 patent is extended or adjusted under 35 5,919,439 A * 7/1999 Torgenson et al. ..... 424/70.122 U.S.C. 154(b) by 0 days. * cited by examiner This patent is Subiect to a terminal dis- Primary Examiner Thurman- K. Page p ASSistant Examiner-Liliana Di Nola-Baron claimer. (74) Attorney, Agent, or Firm-Brent M. Peebles (21) Appl. No.: 09/342,726 (57) ABSTRACT (22) Filed: Jun. 29, 1999 The present invention relates to water or alcohol soluble or dispersible Silicone grafted thermoplastic elastomeric Related U.S.
    [Show full text]
  • Aldrich Phosphorus and Sulfur Compounds
    Aldrich Phosphorus and Sulfur Compounds Library Listing – 822 spectra Subset of Aldrich FT-IR Library related aldehydes and ketones. The Aldrich Material-Specific FT-IR Library collection represents a wide variety of the Aldrich Handbook of Fine Chemicals' most common chemicals divided by similar functional groups. These spectra were assembled from the Aldrich Collections of FT-IR Spectra Editions I or II, and the data has been carefully examined and processed by Thermo Fisher Scientific. Aldrich Phosphorus and Sulfur Compounds Index Compound Name Index Compound Name 245 ((1R)-(ENDO,ANTI))-(+)-3- 651 (2S)-(+)-GLYCIDYL 3- BROMOCAMPHOR-8- SULFONIC NITROBENZENESULFONATE,99% ACID, AMMONIUM SALT 649 (2S)-(+)-GLYCIDYL TOSYLATE, 246 ((1S)-(ENDO,ANTI))-(-)-3- 99% BROMOCAMPHOR-8- SULFONIC 352 (3,4-TOLUENEDITHIOLATO(2- ACID, AMMONIUM SALT ))ZINC HYDRATE 292 (+)-10- 402 (3- DICYCLOHEXYLSULFAMOYL-L- CHLOROPROPYL)DIPHENYLSULF ISOBORNEOL, 98% ONIUM TETRAFLUORO- BORATE, 242 (+/-)-10-CAMPHORSULFONIC ACID 97% MONOHYDRATE, 98% 295 (7R)-10,10-DIMETHYL-5-THIA-4- 243 (+/-)-10-CAMPHORSULFONIC ACID, AZATRICYCLO- (5.2.1.03,7)DEC-3- SODIUM SALT, 97% ENE-5,5-D 778 (-)-1-CHLORO-3-TOSYLAMIDO-7- 296 (7S)-10,10-DIMETHYL-5-THIA-4- AMINO-2- HEPTANONE AZATRICYCLO- (5.2.1.03,7)DEC-3- HYDROCHLORIDE, 98% ENE-5,5-D 291 (-)-10- 488 (PHENYLSULFINYL)(PHENYLSULF DICYCLOHEXYLSULFAMOYL-D- ONYL)METHANE, 95% ISOBORNEOL, 98% 439 (PHENYLSULFONYL)ACETONITRI 629 (-)-2,3-BUTANEDIOL DI-P- LE, 98% TOSYLATE, 99% 417 (R)-(+)-METHYL P-TOLYL 306 (-)-SINIGRIN MONOHYDRATE, 98% SULFOXIDE, 99%
    [Show full text]
  • Studies on the Physiological Role of Taurine in Mammalian Tissues'
    STUDIES ON THE PHYSIOLOGICAL ROLE OF TAURINE (2-aminoethane sulfonic acid) IN MAMMALIAN TISSUES by MOHAMED AKBERALI REMTULLA B.Sc, University of British Columbia, 1974 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE.DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE STUDIES in THE DEPARTMENT OF PATHOLOGY (Faculty of Medicine) We accept this thesis as conforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA AUGUST, 1979 (e) Mohamed Akberali Remtulla, 19 79 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the Head of my Department or by his representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department of The University of British Columbia 2075 Wesbrook Place Vancouver, Canada V6T 1W5 ii ABSTRACT 'Studies on the Physiological Role of Taurine in Mammalian Tissues' Mohamed A. Remtulla Ph.D. (Pathology) Taurine (2-aminoethane sulfonic acid) is one of the most abundant free amino acids found in mammalian brain, heart and muscle. Taurine levels have also been shown to be altered in certain disease states. A physiological role for taurine in the maintainance of excitatory activity in muscle and nervous tissues has been suggested; however its possible mechanism of action is still uncertain. Early work on the pharmacological actions of taurine involved its possible conversion to isethionic acid (2-hydroxyethane sulfonic acid), a strong anion.
    [Show full text]
  • New Intermediates, Pathways, Enzymes and Genes in the Microbial Metabolism of Organosulfonates
    New intermediates, pathways, enzymes and genes in the microbial metabolism of organosulfonates Dissertation zur Erlangung des akademischen Grades des Doktors der Naturwissenschaften (Dr. rer. nat.) an der Universität Konstanz Fachbereich Biologie vorgelegt von Sonja Luise Weinitschke Konstanz, Dezember 2009 Tag der mündlichen Prüfung: 26.02.2010 1. Referent: Prof. Dr. Alasdair M. Cook 2. Referent: Prof. Dr. Bernhard Schink „In der Wissenschaft gleichen wir alle nur den Kindern, die am Rande des Wissens hier und da einen Kiesel aufheben, während sich der weite Ozean des Unbekannten vor unseren Augen erstreckt.“ Sir Isaac Newton Meiner Familie gewidmet Contributions during my PhD thesis to other projects than mentioned in the main Chapters: Denger, K., S. Weinitschke, T. H. M. Smits, D. Schleheck and A. M. Cook (2008). Bacterial sulfite dehydrogenases in organotrophic metabolism: separation and identification in Cupriavidus necator H16 and in Delftia acidovorans SPH-1. Microbiology 154: 256-263. Krejčík, Z., K. Denger, S. Weinitschke, K. Hollemeyer, V. Pačes, A. M. Cook and T. H. M. Smits (2008). Sulfoacetate released during the assimilation of taurine-nitrogen by Neptuniibacter caesariensis: purification of sulfoacetaldehyde dehydrogenase. Arch. Microbiol. 190: 159-168. Denger, K., J. Mayer, M. Buhmann, S. Weinitschke, T. H. M. Smits and A. M. Cook (2009). Bifurcated degradative pathway of 3-sulfolactate in Roseovarius nubinhibens ISM via sulfoacetaldehyde acetyltransferase and (S)-cysteate sulfo-lyase. J. Bacteriol. 191: 5648-5656. An erster Stelle möchte ich mich herzlich bei Prof. Dr. Alasdair M. Cook bedanken für die Betreuung und die Möglichkeit, an einem so interessanten Projekt forschen zu dürfen. Mein herzlicher Dank gilt außerdem… … Prof.
    [Show full text]
  • The Development and Improvement Of
    FLUORESCENT REAGENTS TO IMPROVE THE ANALYTICAL INFRASTRUCTURE OF CAPILLARY ELECTROPHORETIC SEPARATIONS A Dissertation by MING-CHIEN LI Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY May 2012 Major Subject: Chemistry FLUORESCENT REAGENTS TO IMPROVE THE ANALYTICAL INFRASTRUCTURE OF CAPILLARY ELECTROPHORETIC SEPARATIONS A Dissertation by MING-CHIEN LI Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved by: Chair of Committee, Gyula Vigh Committee Members, Coran Watanabe Daniel Romo Victor Ugaz Head of Department, David H. Russell May 2012 Major Subject: Chemistry iii ABSTRACT Fluorescent Reagents to Improve the Analytical Infrastructure of Capillary Electrophoretic Separations. (May 2012) Ming-Chien Li, B.S., Tankang University; M.S., National Tsing Hua University Chair of Advisory Committee: Dr. Gyula Vigh Two types of fluorescent molecules had been designed and synthesized to improve the analytical infrastructure of capillary electrophoretic separations. First, a hydrophilic version of the permanently cationic acridine-based fluorophore, HEG2Me2-DAA was ex synthesized. HEG2Me2-DAA has a λ max of 490 nm which matches the 488 nm line of the commonly used argon ion laser. The emission spectra of HEG2Me2-DAA are pH- independent. HEG2Me2-DAA was used in capillary electrophoresis with an aqueous background electrolyte and was found to be free of the detrimental peak tailing of the acridine orange-based fluorophore that was caused by adsorption on the inner wall of the fused silica capillary. Bovine serum albumin was labeled with excess of the designed amine reactive reagent and the lowest concentration at which the tagged bovine serum albumin was tested was 15 nM.
    [Show full text]
  • Harry's Cosmeticology 9Th Edition Volume 2
    NINTH EDITION Harry’s Cosmeticology Harry’s Cosmeticology 9th Edition © 2015 Chemical Publishing Co., Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning or otherwise, except as permitted under Sections 107 or 108 of the 1976 United Stated Copyright Act, without either the prior written permission of the Publisher. Requests to the Publisher for permission should be addressed to the Publisher, Chemical Publishing Company, through email at [email protected]. The publisher, editors and authors make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation warranties of fitness for a particular purpose. Volume One - ISBN: 978-0-8206-01762 Volume Two - ISBN: 978-0-8206-01779 Volume Three - ISBN: 978-0-8206-01786 eBook - ISBN: 978-0-8206-01793 First Edition Chemical Publishing Company www.chemical-publishing.com Printed in the United States of America About the Editor-in-Chief Meyer R. Rosen CChem, CPC, CChE, CFEI, DABFE, DABFET, FAIC Meyer R. Rosen is President of Interactive Consulting, Inc. (www.chemicalconsult.com). He is a Thought-Leader and expert in the field of Technical Marketing and multi-industry Technology Transfer Applications including, but not limited to: cosmetics and personal care, applied rheology, applied surface and interfacial chemistry, polymers, organosilicones, professional editing and custom preparation of Mind-Maps® for the organization and presentation of complex information. Mr. Rosen is a Chartered Chemist and Fellow of the Royal Society of Chemistry (London); a Fellow of the American Institute of Chemists and both a Nationally Certified Professional Chemist and Certified Professional Chemical Engineer.
    [Show full text]